Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124

Key Points Coronary angiography has limitations in assessing left main coronary artery (LMCA) disease and guiding treatment. The complementary use of coronary physiology and imaging modalities is helpful to improve outcomes following LMCA stenting. Long-term prognosis following ostial or shaft…

Key Points Always consider an ostial lesion as a possible bifurcation lesion, except in cases of aortoostial location. A 6-Fr guiding catheter is appropriate most of the time; when in doubt, use 7- or 8-Fr. Do not risk losing the…

Key Points Cardiogenic shock (CS) remains the leading cause of death among patients hospitalized with acute myocardial infarction (AMI). Left ventricular (LV) dysfunction accounts for most CS in AMI patients. Early restoration of perfusion to the territory supplied by the…

Key Points Comprehensive post-percutaneous coronary intervention (PCI) discharge management is an integral aspect of postprocedure care and includes direct patient communication, monitoring for procedural or vascular complications, and clear discharge instructions with a specific follow-up plan. Medication reconciliation, especially regarding…

Key Points Catheter-based primary percutaneous coronary intervention (PPCI) has become the mainstay of reperfusion therapy in patients with ST-elevation myocardial infarction (STEMI). PPCI is superior to thrombolytic therapy in reducing death, reinfarction, intracranial bleeding, reocclusion of the infarct-related artery, and…

Key Points All patients with non–ST-segment elevation acute coronary syndromes (NSTE-ACS) need to undergo risk stratification at the time of diagnosis. Risk stratification provides prognostic value and helps guide the therapeutic decision-making process. Immediate angiography within 2 hours is recommended…

Key Points Chronic angina is a growing worldwide problem with significant economic and societal costs. By reducing the ischemic burden, percutaneous coronary revascularization provides important clinical benefit in patients with established obstructive coronary artery disease (CAD). The foremost effect is…

Key Points Drug-coated balloon (DCB) catheters are the most advanced proven alternative to drug-eluting stents for local intravascular drug delivery. Preclinical data indicate effective inhibition of restenosis; however, there is no uniform class effect on drug-coated balloons. Randomized clinical trials…

Key Points Bioresorbable scaffolds (BRS) have the potential to overcome the remaining limitations of new generation drug eluting stents (DES) by providing temporary vessel scaffolding and then disappearing. They are composed of either polymer or corrodible metal-based alloys and the…

Key Points Bare-metal stents (BMS) overcome many of the drawbacks of balloon angioplasty but are limited by restenosis, which develops in 20% to 40% of cases. Drug-eluting stents (DES)—which consist of a metallic stent coated with a drug carrier vehicle…